Adjuvant Global Health Technology Fund DE, L.P.
Shareholder at ANTX
- Sold, on record
- $265k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Sep 28, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ANTXAN2 Therapeutics, Inc.Shareholder
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ANTXNo planSep 7, 2023 2023
Sold 7,140 shares at $16.03 ($114k)
Adjuvant Global Health Technology Fund DE, L.P., 10% owner
No 10b5-1 planSold 0.3% of holdings ($35M position)2.2M shares leftFirst sale on recordFiling
- 2 Form 4 sale ANTXNo planSep 28, 2023 +21 days
Sold 9,357 shares at $16.11 ($151k)
Adjuvant Global Health Technology Fund DE, L.P., 10% owner
No 10b5-1 planSold 0.4% of holdings ($35.1M position)2.2M shares leftFiling
- 3 Form 144 notice ANTXNoticeJan 16, 2024 +110 days
Filed to sell 15,907 shares ($332k)
Adjuvant Global Health Technology Fund DE, L.P., Shareholder
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Jan 16, 2024 | ANTX | Shareholder | Form 144 notice | 15,907 | $332k | Notice | SEC | |
| Sep 28, 2023 | Sep 29, 2023 | ANTX | 10% owner | Form 4 sale | 9,357 | $151k | 0.4% | No plan | SEC |
| Sep 7, 2023 | Sep 8, 2023 | ANTX | 10% owner | Form 4 sale | 7,140 | $114k | 0.3% | No plan | SEC |